(Q37582663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

E L Hogan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

1 reference

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1011-1029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Minireview: autoimmune responses to myelin proteolipid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Myelin glycolipids and their functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Self glycolipids as T-cell autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

How T lymphocytes recognize lipid antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Biological markers for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Biomarkers in multiple sclerosis: role of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Glycolipids as immune modulatory tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Antigen-specific therapies in MS - Current concepts and novel approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Central nervous system myelin: structure, function, and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The lipid composition of purified bovine brain myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Lipid composition of myelin in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Identification of an organ specific lipid hapten in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Generation and biological properties of a monoclonal antibody to Galactocerebroside

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Demyelination produced by experimental allergic neuritis serum and anti-galactocerebroside antiserum in CNS cultures. An ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li+ adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Removal of phospho-head groups of membrane lipids immobilizes voltage sensors of K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Regulation of ganglioside biosynthesis in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Myelin in multiple sclerosis. Composition of myelin from normal-appearing white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Gangliosides and Glycerophospholipids in Multiple Sclerosis White Matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Ganglioside abnormalities in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Lipid alterations in apparently normal white matter in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

CSF and serum ganglioside antibody patterns in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Evidence for a role of gammadelta T cells in demyelinating diseases as determined by activation states and responses to lipid antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Preliminary observations of gangliosides of normal and multiple sclerosis cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Serum ganglioside patterns in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Two new trifunctional antibodies for the therapy of human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Axonal loss in normal-appearing white matter in a patient with acute MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Axonal degeneration and progressive neurologic disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A change in the cerebrosides and sulfatides in a demyelinating nervous system. Development of the methodology and study of multiple sclerosis and Wallerian degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Maturation of human white matter myelin. Fractionation of the myelin membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Biochemistry of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Lipid microarrays identify key mediators of autoimmune brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A sulfatide-reactive monoclonal antibody derived from a patient with multiple sclerosis binds to myelin in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A sulfatide-reactive human monoclonal antibody obtained from a multiple sclerosis patient selectively binds to the surface of oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Galactocerebroside and sulfatide independently mediate Ca2+ responses in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

[Multiple sclerosis and antiphospholipid antibodies: study of 62 consecutive patients].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Cerebrospinal fluid anti-cardiolipin antibodies in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The interface of multiple sclerosis and antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Lysolecithin induces demyelination in vitro in a cerebellar slice culture system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

High cholesterol level is essential for myelin membrane growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Axo-glial interactions regulate the localization of axonal paranodal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Galactolipids are molecular determinants of myelin development and axo-glial organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Phosphatidic acid mediates demyelination in Lpin1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Multiple sclerosis: a complicated picture of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Immunological aspects of demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Oligoclonal bands and antibody responses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Comprehensive viral immunology of multiple sclerosis. II. Analysis of serum and CSF antibodies by standard serologic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

In vitro synthesis of antibodies to myelin antigens by Epstein-Barr virus-transformed B lymphocytes from patients with neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Measles virus-specific human T cell clones: studies of alloreactivity and antigenic cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Mechanisms for the induction of autoimmunity by infectious agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Pathogenetic role of autoantibodies in neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Immunological markers in multiple sclerosis: tackling the missing elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Multiple sclerosis: disease biomarkers as indicated by pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Antibodies as biological markers for pathophysiological processes in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Synergism in the pathogenesis of EAE induced by an MBP-specific T-cell line and monoclonal antibodies to galactocerebroside or a myelin oligodendroglial glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Analysis of a predominant immunoglobulin population in the cerebrospinal fluid of a multiple sclerosis patient by means of an anti-idiotypic hybridoma antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Natural killer T cells as targets for immunotherapy of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Immunoregulation of autoimmunity by natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Glycolipids for natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Going both ways: immune regulation via CD1d-dependent NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A biased Valpha24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Recognition of lipid antigens by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Mechanisms of lipid-antigen generation and presentation to T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Presentation of the same glycolipid by different CD1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Murine CD1d-restricted T cell recognition of cellular lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Lysosomal glycosphingolipid recognition by NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Cross-presentation of disialoganglioside GD3 to natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Mini review: immune response to myelin-derived sulfatide and CNS-demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

How T cells get grip on lipid antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

CD1-mediated antigen presentation of glycosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Prospects of cell therapy for disorders of myelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Immunoglobulin-mediated CNS repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Invited article: human natural autoantibodies in the treatment of neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Glial cell transplantation and remyelination of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

The role of glycosphingolipids in neurological disorders. Mechanisms of immune action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Prevalence and Clinical Significance of Anti-phospholipid Antibodies in Multiple Sclerosis: a Study of 89 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106708

21 January 2018

Identifiers

DOI

10.1177/1352458509106708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692432%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference